Member Info for Geovanni

Thanks Xeno

Could someone please upload the Swedish chat board. I seem to have lost it and this could now getting interesting for Beowulf. Thank you.

The Chairperson ended by saying something like

'we await the future with no little anticipation and excitement for the company''

I thought that was impressive. The closing statement from the Chairperson will go down in corporate history as one of the classic definitive examples of English reserve.

The Merck announcement was at 7am NY time which coincides with 11am London Time. That was the moment that the Synairgen share price started to rocket.

The Merck drug isn't that great and they do not expect to complete the Phase 3 trial until Autumn. This represents a good read-across for Synairgen getting an early EUA

https://www.bbc.co.uk/news/world-latin-america-57408371

Includes an interesting piece on monoclonal antibody use in a particular cohort of patients - from 31:00 to 35:40mins

https://www.bbc.co.uk/news/world-latin-america-57341542

If this treatment is one of the three the EU intend to announce this month as worthy of supporting to accelerate development and availability, then there will be no need for any shareholder fundings.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734101/

The treatment described in this 6 month old research paper relates to the use in France of the Novartis Extavia Interferon Beta 1b product, in a cobbled-together inhalation format. It is worth reading again as we await Olivier Veran (Health Minister of France) announcing trial results, which are expected any day now. As far as I am aware Synairgen has the patent, so the trial readout should be very positive for Synairgen.

I think this might explain RM's comment made in two recent radio stations, that breathless outpatients will be the subject of an international trial. This would be an extension of ACTIV2.

https://www.youtube.com/watch?v=LfwyLAH9d64

This is 30 minutes of AN with a good Q&A. Starts at 1:23:27 to 1:54:00

http://amatiglobal.com/videos.php?id=26

Han**** spoke about this today around 5.10pm on R5. He said they are expecting to announce two treatments soon

https://finance.yahoo.com/news/1-u-fda-gives-emergency-215546945.html

Slightly more info in this link

Yes. the mention of another trial means that the USA are taking it further.

Why would he be in the USA unless it is to meet NIH. Something is ACTVIly brewing

https://event.webinarjam.com/register/1082/k667yt2lz?j=764984&sfmc_sub=207589223&l=86_HTML&u=43082360&mid=100009383&jb=58

https://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/bcp.14898

Downloaded from twitter. This is the report on the China study found in the pdf document. The section of particular interest is the discussion towards the end of this report.

https://www.fda.gov/drugs/drug-safety-and-availability/statement-leronlimab

Good find Sheephatch